Yu Seong-Woon, Wang Hongmin, Dawson Ted M, Dawson Valina L
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Neurobiol Dis. 2003 Dec;14(3):303-17. doi: 10.1016/j.nbd.2003.08.008.
Poly(ADP-ribose) polymerase-1 (PARP-1) is the guardian of the genome acting as a sentinel for genomic damage. However, PARP-1 is also mediator of cell death after ischemia-reperfusion injury, glutamate excitotoxicity, and various inflammatory processes. The biochemistry underlying PARP-1-mediated cell death has remained elusive, although NAD(+) consumption and energy failure have been thought to be one of the possible molecular mechanisms. Recent observations link PARP-1 activation with translocation of apoptosis-inducing factor (AIF) to the nucleus and indicate that AIF is an essential downstream effector of PARP-1-mediated cell death. PARP-1 activation signals AIF release from the mitochondria, resulting in a novel, caspase-independent pathway of programmed cell death. These recent findings suggest that AIF maybe a target for development of future therapeutic treatment for many neurological disorders involving excitotoxicity.
聚(ADP - 核糖)聚合酶 -1(PARP -1)是基因组的守护者,充当基因组损伤的哨兵。然而,PARP -1也是缺血再灌注损伤、谷氨酸兴奋性毒性和各种炎症过程后细胞死亡的介质。尽管NAD(+)消耗和能量衰竭被认为是可能的分子机制之一,但PARP -1介导的细胞死亡背后的生物化学机制仍不清楚。最近的观察结果将PARP -1激活与凋亡诱导因子(AIF)转位至细胞核联系起来,并表明AIF是PARP -1介导的细胞死亡的重要下游效应物。PARP -1激活信号促使AIF从线粒体释放,导致一种新的、不依赖半胱天冬酶的程序性细胞死亡途径。这些最新发现表明,AIF可能是未来开发针对许多涉及兴奋性毒性的神经疾病治疗方法的靶点。